دورية أكاديمية
The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis.
| العنوان: | The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis. |
|---|---|
| المؤلفون: | Jeong JU; Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Chonnam National University College of Medicine, Hwasun, Korea., Rim CH; Department of Radiation Oncology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea., Yoo GS; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea., Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee JH; Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea. |
| مؤلفون مشاركون: | Korean Oligometastasis Working Group, Korean Cancer Association |
| المصدر: | Cancer research and treatment [Cancer Res Treat] 2024 Jul; Vol. 56 (3), pp. 809-824. Date of Electronic Publication: 2023 Dec 14. |
| نوع المنشور: | Journal Article; Meta-Analysis |
| اللغة: | English |
| بيانات الدورية: | Publisher: The Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-9256 (Electronic) Linking ISSN: 15982998 NLM ISO Abbreviation: Cancer Res Treat Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Seoul, Korea : The Association, |
| مواضيع طبية MeSH: | Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/radiotherapy , Colorectal Neoplasms*/mortality , Radiosurgery*/methods , Radiosurgery*/adverse effects , Lung Neoplasms*/radiotherapy , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Lung Neoplasms*/secondary, Humans ; Treatment Outcome |
| مستخلص: | Purpose: There is increasing interest in the efficacy of stereotactic ablative radiotherapy (SABR) for treating colorectal cancer (CRC) patients with oligometastases (OM), recently. The purpose of this meta-analysis was to evaluate local control (LC), progression-free survival (PFS), and overall survival (OS) of CRC patients with pulmonary OM treated with SABR and toxicities. Materials and Methods: Studies that reported SABR for CRC patients with pulmonary OM were searched from MEDLINE and Embase. Treatment outcomes including LC, PFS, OS, and toxicities of grade 3 or higher were assessed. Results: A total of 19 studies with 1,668 patients were chosen for this meta-analysis. Pooled 1-, 2-, and 3-year LC rates were 83.1%, 69.3%, and 63.9%, respectively. PFS rates were 44.8%, 26.5%, and 21.5% at 1, 2, and 3 years, respectively. OS rates at 1-, 2-, and 3-year were 87.5%, 69.9%, and 60.5%, respectively. The toxicity rate of grade 3 or higher was 3.6%. The effect of dose escalation was meta-analyzed using available studies. Conclusion: Application of SABR to CRC patients with pulmonary OM achieved modest local control with acceptable toxicity according to the present meta-analysis. Further studies establishing the clinical efficacy of SABR are guaranteed. |
| References: | Stat Med. 2002 Jun 15;21(11):1539-58. (PMID: 12111919) Radiother Oncol. 2022 Jan;166:92-99. (PMID: 34748855) Clin Colorectal Cancer. 2017 Mar;16(1):58-64. (PMID: 27522627) J Clin Oncol. 2009 Apr 1;27(10):1572-8. (PMID: 19255321) BMC Cancer. 2020 May 11;20(1):404. (PMID: 32393261) Am J Clin Oncol. 2021 Nov 1;44(11):559-564. (PMID: 34534143) J Radiat Res. 2020 Nov 16;61(6):935-944. (PMID: 32940330) Eur J Cancer. 2006 Sep;42(14):2212-21. (PMID: 16904315) Radiother Oncol. 2022 Feb;167:187-194. (PMID: 34952002) Radiother Oncol. 2023 Jul;184:109671. (PMID: 37059336) J BUON. 2015 Jan-Feb;20(1):158-65. (PMID: 25778311) Ann Thorac Surg. 2009 Jun;87(6):1684-8. (PMID: 19463577) Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. (PMID: 19622511) J Cancer Res Clin Oncol. 2020 May;146(5):1227-1234. (PMID: 32056005) Clin Exp Metastasis. 2019 Aug;36(4):331-342. (PMID: 31165360) Acta Oncol. 2006;45(7):808-17. (PMID: 16982544) Oncotarget. 2015 Nov 17;6(36):38658-66. (PMID: 26484417) Eur J Epidemiol. 2010 Sep;25(9):603-5. (PMID: 20652370) Clin Oncol (R Coll Radiol). 2016 Aug;28(8):505-12. (PMID: 26899780) Radiother Oncol. 2017 May;123(2):227-233. (PMID: 28274491) Radiother Oncol. 2022 Mar;168:256-264. (PMID: 35101466) Strahlenther Onkol. 2020 Sep;196(9):813-820. (PMID: 32399637) Ann Surg Oncol. 2010 Aug;17(8):2045-50. (PMID: 20151212) World J Gastroenterol. 2015 Nov 7;21(41):11767-76. (PMID: 26557001) Biometrics. 2000 Jun;56(2):455-63. (PMID: 10877304) Radiat Oncol. 2015 Nov 21;10:238. (PMID: 26588896) Anticancer Res. 2017 Jan;37(1):315-319. (PMID: 28011508) J Clin Oncol. 1995 Jan;13(1):8-10. (PMID: 7799047) Radiother Oncol. 2020 Mar;144:23-29. (PMID: 31710940) Radiother Oncol. 2017 May;123(2):218-226. (PMID: 28363484) Am J Clin Oncol. 2018 Jan;41(1):53-58. (PMID: 26270442) BMC Cancer. 2020 Mar 23;20(1):246. (PMID: 32293337) Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1044-1052. (PMID: 26025776) Cancer Treat Rev. 2006 May;32(3):214-28. (PMID: 16546323) Anticancer Res. 2017 May;37(5):2709-2713. (PMID: 28476849) J Radiat Res. 2016 Jan;57(1):55-61. (PMID: 26494115) Nat Rev Clin Oncol. 2011 Jun;8(6):378-82. (PMID: 21423255) Ann Surg. 2023 Jul 1;278(1):e173-e178. (PMID: 35837890) BMJ. 1997 Sep 13;315(7109):629-34. (PMID: 9310563) Cancer. 1996 Apr 1;77(7):1254-62. (PMID: 8608500) Clin Colorectal Cancer. 2017 Sep;16(3):e211-e220. (PMID: 27670890) Lancet. 2018 Dec 1;392(10162):2353-2366. (PMID: 30355464) Cancer Res Treat. 2021 Oct;53(4):1104-1112. (PMID: 33494126) Ann Oncol. 2012 Oct;23(10):2619-2626. (PMID: 22431703) Dis Colon Rectum. 1988 Jan;31(1):1-4. (PMID: 3366020) JAMA Oncol. 2018 Jan 11;4(1):e173501. (PMID: 28973074) Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):1-5. (PMID: 37574234) Medicine (Baltimore). 2017 Dec;96(50):e9249. (PMID: 29390360) BMC Cancer. 2014 Aug 27;14:619. (PMID: 25163798) Int J Colorectal Dis. 2007 Jun;22(6):699-704. (PMID: 17109105) J Clin Oncol. 2019 Jun 20;37(18):1558-1565. (PMID: 31067138) Trials. 2019 Dec 12;20(1):718. (PMID: 31831062) Radiother Oncol. 2019 Apr;133:113-119. (PMID: 30935566) |
| فهرسة مساهمة: | Keywords: Ablation; Colorectal neoplasms; Lung; Oligometastasis; Radiotherapy |
| تواريخ الأحداث: | Date Created: 20231215 Date Completed: 20240717 Latest Revision: 20240724 |
| رمز التحديث: | 20240725 |
| مُعرف محوري في PubMed: | PMC11261202 |
| DOI: | 10.4143/crt.2023.920 |
| PMID: | 38097919 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2005-9256 |
|---|---|
| DOI: | 10.4143/crt.2023.920 |